A common bug called respiratory syncytial virus (RSV) circulating among American kids during what’s normally its off-season may cause concern if parents don’t know how to tell it apart from COVID-19, experts say. Getting RSV during the summer is unusual, but the U.S. Centers for Disease Control and Prevention recently issued an alert about a… read on > read on >
You’ve just bought a new skin care product and you’re excited to see how it might transform your look. Instead, you end up with red, itchy or swollen patches because one of the ingredients causes an allergic reaction. The best way to avoid this problem while trying something new is to test it on several… read on > read on >
Heart attack survivors could gain more than seven healthy years of life if they take the right medications and improve their lifestyle, new research estimates. Unfortunately, studies have found, heart attack survivors rarely get optimal control over their risk factors. The new research echoes that evidence: Of more than 3,200 patients, only 2% had their… read on > read on >
A first-of-a-kind nerve stimulation treatment for people who have problems moving their arms after a stroke has been approved by the U.S. Food and Drug Administration. “People who have lost mobility in their hands and arms due to ischemic stroke are often limited in their treatment options for regaining motor function,” explained Dr. Christopher Loftus.… read on > read on >
Three small e-cigarette makers have been told by the U.S. Food and Drug Administration to stop selling their flavored products. The orders issued Thursday to JD Nova Group LLC, Great American Vapes and VaporSalon require them to remove 55,000 existing or planned flavored products from the market or risk enforcement, the Washington Post reported. In… read on > read on >
FRIDAY, Aug. 27, 2021 (American Heart Association News) — They are words nobody wants to hear: Alzheimer’s disease and dementia. As the population ages, a growing number of older adults gradually lose cherished memories and the ability to think and, ultimately, to perform even the most basic functions of daily living. Researchers say dementias are… read on > read on >
Nearly half of coronavirus patients in a large, new study were still suffering at least one lingering symptom of their illness a full year after being hospitalized for COVID-19. The latest findings add to a growing pile of evidence that suggests recovery is no easy task with this virus. Published Thursday in The Lancet journal,… read on > read on >
A drug that lowers cholesterol might help save hospitalized patients with COVID-19, a new, small Israeli study suggests. Researchers at Hebrew University of Jerusalem noted that COVID causes a big buildup of cholesterol, which results in inflammation in cells. In lab experiments, they found that the cholesterol-lowering drug fenofibrate (TriCor) effectively reduced damage to lung… read on > read on >
It can happen in an instant. A young child climbs a heavy piece of furniture, and it topples over on the toddler. New research suggests that’s not as rare as you might think: Hundreds of thousands of children have been treated in U.S. emergency rooms for such injuries in recent decades. “Some families may not… read on > read on >
New research delivers an answer to a burning question: When are COVID-19 patients most infectious? The answer? Two days before and three days after they develop symptoms. The findings highlight the importance of rapid testing and quarantine if someone is feeling sick, the study authors said. The researchers also found that infected people are more… read on > read on >
